Digital Acceptance and Commitment Therapy for Lifestyle Change in Overweight Pregnant Women: A Feasibility Pilot Study

数字化接纳与承诺疗法在超重孕妇生活方式改变中的应用:一项可行性试点研究

阅读:1

Abstract

Overweight and obesity during pregnancy are associated with increased maternal and neonatal risks, yet scalable interventions addressing the psychological processes underlying health behaviours remain limited. This study describes the development and formative evaluation of DEMETRA, a chatbot delivering an Acceptance and Commitment Therapy (ACT)-informed intervention to promote healthier lifestyles in pregnant women. In line with Phase 1 of the Obesity-Related Behavioral Intervention Trials framework, a multidisciplinary team developed a six-session digital program delivered via a rule-based virtual assistant. A mixed-methods design was employed to assess acceptability, usability, and perceived relevance among a heterogeneous stakeholder sample. Sixteen stakeholders (psychologists, communication experts, nutritionists, clinicians, and non-overweight, expectant women or those who had recently delivered) participated in iterative testing; 15 completed quantitative measures (Semantic Differential scales, uMARS, BUS-11) and 16 completed semi-structured interviews. Non-parametric analyses indicated significantly positive evaluations across most communication and content domains, particularly clarity and language appropriateness, whereas session duration and several engagement-related dimensions did not significantly differ from neutrality. Qualitative findings confirmed strengths in clarity, non-stigmatising tone, and multimedia support, while identifying limited personalisation and message pacing as key areas for refinement. Overall, findings provide formative evidence that ACT-informed principles can be translated into a chatbot-delivered antenatal program and highlight concrete priorities for optimisation (e.g., personalisation and message pacing). Because end-user testing did not include overweight/obese pregnant women and the sample was small and heterogeneous, conclusions regarding acceptability/feasibility in the intended clinical population remain preliminary; the results primarily support iterative refinement and subsequent proof-of-concept testing in the target group.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。